Keymed launches $400m Hong Kong IPO
![Pharma_drugs_adobe_575x375.jpg](https://assets.euromoneydigital.com/dims4/default/b01b394/2147483647/strip/true/crop/575x375+0+0/resize/840x548!/quality/90/?url=http%3A%2F%2Feuromoney-brightspot.s3.amazonaws.com%2Fe0%2F58%2F8ce0fc2a15cc3f1ce9a75517fd9a%2Fpharma-drugs-adobe-575x375.jpg)
Chinese biotechnology company Keymed Biosciences has hit the market with an up to HK$3.1bn ($400.1m) IPO.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: